Article
Efficacy of hepatitis B immunoglobulin in relation to the gene polymorphisms of human leukocyte Fcgamma receptor III (CD16) in Chinese liver transplant patients.
Chinese medical journal - 20 Sept 2007
Wang Wei-Lin, Zhang Guo-Liang, Wu Li-Hua, Yao Min-Ya, Jin Jing, Jia Chang-Ku, Xie Hai-Yang, Zhou Lin, Jiang Zhi-Jun, Zheng Shu-Sen
Abstract excerpt
BACKGROUND: Although the use of hepatitis B immunoglobulin (HBIG) may lead to a significant reduction in recurrent hepatitis B virus (HBV) infection and improve the survival of patients who have undergone liver transplantation (LT) for hepatitis B-related diseases, the recurrence of the disease still remains at a lower level. Different clinical curative effects were observed in patients with the same HBV-related...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.